Delivery Order SPE2DR25D3202-SPE2DR26F8E5B
Award Date 1/13/26
Potential Completion Date 1/14/26
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp (subsidiary of Cencora, Inc.) on January 14, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 tablets, with a ceiling value of $1,802.78 and an ultimate completion date of January 15, 2026. The contract utilizes a firm fixed-price structure with no small business set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $16,011.56 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 12, 2026, with completion targeted for January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used primarily for hepatitis B treatment, reflecting the...
- The Defense Logistics Agency awarded a $15,016.53 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Vemlidy 25 mg on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,079.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the type of specialized...
- The Defense Logistics Agency awarded a delivery order valued at $20,721.48 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a delivery order valued at $8,204.95 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) valued at $20,196.06 under a firm fixed-price contract. This non-set-aside award was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Vemlidy is an antiviral medication used in hepatitis B treatment, consistent with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,656.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). This contract was competitively awarded with firm fixed pricing and no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,624.87 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (quantity 30) on December 19, 2025, with completion expected by December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the...